S&P 500 Healthcare Sector SPDR (XLV)

Although Becton, Dickinson and Company has underperformed its sector peers recently, analysts remain moderately optimistic about the stock’s prospects.

Zoetis has underperformed its industry peers over the past year, yet Wall Street remains optimistic about the stock.

While Cigna has lagged behind the broader healthcare sector over the past year, Wall Street analysts remain highly bullish about the stock’s prospects.

Gilead Sciences has outperformed the healthcare sector, and analysts remain highly optimistic about the stock’s outlook

Boston Scientific has considerably underperformed its sector peers recently, yet analysts remain highly optimistic about the stock’s prospects.

Despite Vertex Pharmaceuticals' underperformance relative to the healthcare sector over the past year, Wall Street analysts remain strongly optimistic about the stock’s prospects.

Elevance Health has underperformed the Health Care sector over the past year, but analysts are moderately optimistic about the stock’s prospects.

Despite recent underperformance relative to the healthcare sector, analysts remain fairly bullish on Intuitive Surgical's long-term fundamentals and growth potential.

Due to Pfizer’s underperformance relative to its peers over the past year, Wall Street analysts remain cautious about the stock’s prospects

Despite Amgen's outperformance relative to the healthcare sector over the past year, Wall Street analysts remain cautiously optimistic about the stock’s prospects.